Galderma Group AG-Unspon ADRGALDY
13F holders, Q2 2026 (June 30)5holders +2
2new positions
0sold out
$45.44avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Galderma Group AG-Unspon ADR (GALDY) in their 13F filings, up 2 from Q1 2026. 2 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($1.4M), PNC Financial Services Group, Inc. ($147K) and GAMMA Investing LLC ($58K).
- Company
- Galderma Group AG-Unspon ADR
- CUSIP
- 36321W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $70K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 9,388 shares bought and 257 shares sold, net +9,131 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Rhumbline Advisers | 0.00% | Add +27.8% | 30,607 | $1.4M |
| PNC Financial Services Group, Inc. | 0.00% | Add +58.1% | 3,224 | $147K |
| GAMMA Investing LLC | 0.00% | New | 1,270 | $58K |
| Salomon & Ludwin, LLC | 0.00% | Reduce -24.6% | 789 | $35K |
| IMA Advisory Services, Inc. | 0.00% | New | 268 | $12K |
"% of holder's portfolio" is GALDY's weight in each manager's 13F, not the share of Galderma Group AG-Unspon ADR the manager owns.